"Must have access to credible information"
Singapore | Influencers | By BioSpectrum Bureau | 0 Comment | 09 Dec, 2015
How can technology be instrumental and more effective in empowering patients to manage diseases? Technology which can p...Read more
Sartorius Stedim enhances single-use product portfolio
Singapore | News | By BioSpectrum Bureau | 0 Comment | 03 Jun, 2014
Singapore: Biotechnology supplier company, Sartorius Stedim Biotech, has launched new range of single-use bags, under it...Read more
A*Star man becomes first non-EU scientist to win EMBO YIP award
Singapore | News | By BioSpectrum Bureau | 0 Comment | 19 Nov, 2012
Singapore: Dr Bruno Reversade from A*STAR's Institute of Medical Biology (IMB) is the first scientist, based outside Eu...Read more
Singapore develops animal-free screening platform to predict nephrotoxicity
Singapore | News | By BioSpectrum Bureau | 0 Comment | 09 Oct, 2015
Singapore: Researchers from Singapore's Institute of Bioengineering and Nanotechnology (IBN) have developed an animal-fr...Read more
Singapore | Analysis | By BioSpectrum Bureau | 0 Comment | 05 May, 2014
Healthcare industry is in a period of evolution accelerated by changing demographics and market forces propelled by insu...Read more
Alcon invests $159 mn in eye drug plant in Singapore
Singapore | News | By BioSpectrum Bureau | 0 Comment | 15 Apr, 2014
Singapore: Alcon, global eye care firm, has launched an ophthalmic pharmaceutical manufacturing facility in Singapore to...Read more
F&S: Private hospital sector to grow in APAC
Singapore | Analysis | By BioSpectrum Bureau | 0 Comment | 07 Feb, 2013
Singapore: About 180 million new hospital beds will be needed over the next decade to meet the rising healthcare demand ...Read more
Health Sciences Authority signs MoU to promote public health
Singapore | Regulatory | By BioSpectrum Bureau | 0 Comment | 07 Oct, 2012
Singapore: Singapore's Health Sciences Authority has signed a memorandum of understanding (MoU) with the National Univer...Read more
A*Star peptides help understand Alzheimer's, cancer
Singapore | News | By BioSpectrum Bureau | 0 Comment | 23 Apr, 2013
Singapore: A new class of ultrasmall peptides developed by A*Star's Institute of Bioengineering and Nanotechnology (IBN)...Read more
Mundipharma buys Merck's ophthalmology business
Singapore | News | By BioSpectrum Bureau | 0 Comment | 03 Dec, 2015
Singapore: Mundipharma Ophthalmology Products has announced an agreement with MSD, known as Merck in the United States a...Read more
IBM, A*Star co-develop anti-microbial hydrogel
Singapore | News | By BioSpectrum Bureau | 0 Comment | 24 Jan, 2013
Singapore: Researchers from A*Star's Institute of Bioengineering and Nanotechnology (IBN) and IBM have unveiled first-e...Read more
Pfizer launches targeted therapy for lung cancer in Singapore
Singapore | Regulatory | By BioSpectrum Bureau | 0 Comment | 04 Aug, 2015
Singapore: Pfizer has launched Xalkori, a targeted therapy for ALK-positive non-small cell lung cancer (NSCLC), in Singa...Read more
Singapore | Opinion | By BioSpectrum Bureau | 0 Comment | 19 Jan, 2016
Singapore: Over the past 15 years, Singapore has developed into a renowned bioscience cluster through top-down investmen...Read more
HSA nod for Aslan rheumatoid arthritis drug
Singapore | Regulatory | By BioSpectrum Bureau | 0 Comment | 23 Apr, 2013
Singapore: Aslan Pharmaceuticals received approval by the Singapore Health Sciences Authority (HSA) for its Clinical Tri...Read more
Covance recieves Frost and Sullivan Award
Singapore | News | By BioSpectrum Bureau | 0 Comment | 17 Oct, 2014
Singapore: Covance, a global drug development company, has recieved the 2014 Frost & Sullivan Asia Pacific CRO Growt...Read more
Challenge No 5: Talent trouble
Singapore | Analysis | By BioSpectrum Bureau | 0 Comment | 17 May, 2012
Lack of trained and skilled workforce, identifying a market-savvy work force and retaining the right people on key posit...Read more
BI shows afatinib to be effective in advanced squamous cell carcinoma of lung
Singapore | News | By BioSpectrum Bureau | 0 Comment | 11 Jun, 2015
Singapore: Boehringer Ingelheim has achieved positive results from the trial of afatinib in comparison to erlotinib in p...Read more
BMS reacquires rights to oncology drug from Asia Partner
Singapore | News | By BioSpectrum Bureau | 0 Comment | 12 Aug, 2016
Singapore: ASLAN Pharmaceuticals (ASLAN), a biotech company focused on the development of immunotherapies and targeted a...Read more